Xing H - Search Results

1

Dysregulated fatty acid metabolism in hepatocellular carcinoma.

Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T. Wang M, et al. Among authors: xing h. Hepat Oncol. 2016 Oct;3(4):241-251. doi: 10.2217/hep-2016-0012. Epub 2017 Jun 30. Hepat Oncol. 2016. PMID: 30191046 Free PMC article. Review.

2

Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.

Zheng H, Yang Y, Wang MC, Yuan SX, Tian T, Han J, Ni JS, Wang J, Xing H, Zhou WP. Zheng H, et al. Among authors: xing h. Surg Oncol. 2016 Sep;25(3):171-7. doi: 10.1016/j.suronc.2016.05.026. Epub 2016 May 24. Surg Oncol. 2016. PMID: 27566019

3

eIF5B increases ASAP1 expression to promote HCC proliferation and invasion.

Wang ZG, Zheng H, Gao W, Han J, Cao JZ, Yang Y, Li S, Gao R, Liu H, Pan ZY, Fu SY, Gu FM, Xing H, Ni JS, Yan HL, Ren H, Zhou WP. Wang ZG, et al. Among authors: xing h. Oncotarget. 2016 Sep 20;7(38):62327-62339. doi: 10.18632/oncotarget.11469. Oncotarget. 2016. PMID: 27694689 Free PMC article.

4

Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.

Xing H, Yan C, Cheng L, Wang N, Dai S, Yuan J, Lu W, Wang Z, Han J, Zheng Y, Yang T. Xing H, et al. Tumour Biol. 2016 Oct 13. doi: 10.1007/s13277-016-5443-x. Online ahead of print. Tumour Biol. 2016. PMID: 27739028 Free article. Review.

5

Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Zhong JH, Torzilli G, Xing H, Li C, Han J, Liang L, Zhang H, Dai SY, Li LQ, Shen F, Yang T. Zhong JH, et al. Among authors: xing h. BBA Clin. 2016 Oct 11;6:125-130. doi: 10.1016/j.bbacli.2016.10.001. eCollection 2016 Dec. BBA Clin. 2016. PMID: 27761414 Free PMC article. Review.

6

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.

Zheng H, Jiang WH, Tian T, Tan HS, Chen Y, Qiao GL, Han J, Huang SY, Yang Y, Li S, Wang ZG, Gao R, Ren H, Xing H, Ni JS, Wang LH, Ma LJ, Zhou WP. Zheng H, et al. Among authors: xing h. Oncotarget. 2017 Mar 21;8(12):18872-18884. doi: 10.18632/oncotarget.14770. Oncotarget. 2017. PMID: 28122351 Free PMC article.

7

Hepatocellular carcinoma surveillance: Sometimes just specialists' incidental behavior?

Zhang H, Li ZL, Xing H, Wu MC, Yang T. Zhang H, et al. Among authors: xing h. Hepatology. 2017 Aug;66(2):672. doi: 10.1002/hep.29200. Epub 2017 Jul 4. Hepatology. 2017. PMID: 28387963 No abstract available.

8

Deadly Sins of Antibiotic Abuse in China.

Wang Z, Zhang H, Han J, Xing H, Wu MC, Yang T. Wang Z, et al. Among authors: xing h. Infect Control Hosp Epidemiol. 2017 Jun;38(6):758-759. doi: 10.1017/ice.2017.60. Epub 2017 Apr 11. Infect Control Hosp Epidemiol. 2017. PMID: 28397628 No abstract available.

9

Reliability and validity analyses are essential for questionnaire research.

Xing H, Liang L, Li ZL, Zhang H, Yang T. Xing H, et al. Hepatology. 2017 Sep;66(3):1008-1009. doi: 10.1002/hep.29295. Epub 2017 Jul 27. Hepatology. 2017. PMID: 28558127 No abstract available.

10

How to better predict microvascular invasion and recurrence of hepatocellular carcinoma.

Xu XF, Yu JJ, Xing H, Shen F, Yang T. Xu XF, et al. Among authors: xing h. J Hepatol. 2017 Nov;67(5):1119-1120. doi: 10.1016/j.jhep.2017.06.034. Epub 2017 Jul 20. J Hepatol. 2017. PMID: 28736140 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,723 results

Search Page